Abstract
Molecular markers for cancers are not only useful for cancer detection and prognostic prediction, but may also serve as potential therapeutic targets. In order to identify reliable molecular markers for prognostic prediction in gallbladder carcinoma (GBC), we evaluated the immunohistochemical expression of 15 proteins, namely p53, p27, p16, RB, Smad4, PTEN, FHIT, GSTP1, MGMT, E-cadherin, nm23, CD44, TIMP3, S100A4, and promyelocytic leukemia (PML) in 138 cases of GBC using the tissue microarray method. The prognostic significance was analyzed for each protein. Overexpression of p53 and S100A4, and loss of p27, p16, RB, Smad4, FHIT, E-cadherin and PML expression were associated with poor survival. In particular, PML and p53 showed considerable potential as independent prognostic markers. Patients with normal PML and p53 expression displayed favorable outcomes, compared to those showing abnormal expression of either or both proteins (49%vs. 23% in a 5-year survival rate; 60 monthsvs. 11 months in median survival, respectively;P=0.009). Thus, PML and p53 are potential candidates for development as clinically applicable molecular prognostic markers of GBC, and may be effective therapeutic targets for the disease in the future.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ajiki T, Fujimori T, Onoyama H, Yamamoto M, Kitazawa S, Maeda S, Saitoh Y: K-ras gene mutation in gall bladder carcinomas and dysplasia. Gut 38:426–429, 1996
Ajiki T, Onoyama H, Yamamoto M, Asaka K, Fujimori T, Maeda S, Saitoh Y: p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions. Hepatogastroenterology 43:521–526, 1996
Albores-Saavedra J. Scoazec JC, Wittekind C, Sripa B, Menck HR, Soehendra N, Sriram PVJ (ed): Carcinoma of the gallbladder and extrahepatic bile ducts. In: Hamilton SR, Aaltonen LA (ed) WHO Classification of Tumors; Pathology and Genetics of Tumors of the Digestive System. IARC Press, Lyon, 2000, pp 203–217
Alkushi A, Lim P, Coldman A, Huntsman D, Miller D, Gilks CB: Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level. Int J Gynecol Pathol 23:129–137, 2004
Chang HJ, Kim SW, Kim YT, Kim WH: Loss of heterozygosity in dysplasia and carcinoma of the gallbladder. Mod Pathol 12:763–769, 1999
Chang HJ, Jee CD, Kim WH: Mutation and altered expression of beta-catenin during gallbladder carcinogenesis. Am J Surg Pathol 26:758–766, 2002
Cubertafond P, Gainant A, Cucchiaro G: Surgical treatment of 724 carcinomas of the gallbladder. Results of the French Surgical Association Survey. Ann Surg 219:275–280, 1994
da Rocha AO, Coutinho LM, Scholl JG, Leboutte LD: The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases. Hepatogastroenterology 51:1310–1314, 2004
El-Deiry WS: The role of p53 in chemosensitivity and radiosensitivity. Oncogene 22:7486–7495, 2003
Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, O’Sullivan B, Sobin LH, Yarbro JW (ed): AJCC cancer staging manual. 5th ed. JB Lippincott, Philadelphia, 1997
Galizia G, Ferraraccio F, Lieto E, Orditura M, Castellano P, Imperatore V, Romano C, Vollaro M, Agostini B, Pignatelli C, De Vita F: Prognostic value of p27, p53, and vascular endothelial growth factor in Dukes A and B colon cancer patients undergoing potentially curative surgery. Dis Colon Rectum 47:1904–1914, 2004
Gurrieri C, Capodieci P, Bernardi R, Scaglioni PP, Nafa K, Rush LJ, Verbel DA, Cordon-Cardo C, Pandolfi PP: Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J Natl Cancer Inst 96:269–279, 2004
House MG, Wistuba II, Argani P, Guo M, Schulick RD, Hruban RH, Herman JG, Maitra A: Progression of gene hypermethylation in gallstone disease leading to gallbladder cancer. Ann Surg Oncol 10:882–889, 2003
Hui AM, Li X, Shi YZ, Torzilli G, Takayama T, Makuuchi M: p27(KIP1) expression in normal epithelia, precancerous lesions, and carcinomas of the gallbladder: association with cancer progression and prognosis. Hepatology 31:1068–1072, 2000
Hui AM, Li X, Shi YZ, Takayama T, Torzilli G, Makuuchi M: Cyclin D1 overexpression is a critical event in gallbladder carcinogenesis and independently predicts decreased survival for patients with gallbladder carcinoma. Clin Cancer Res 6:4272–4277, 2000
Ito H, Matros E, Brooks DC, Osteen RT, Zinner MJ, Swanson RS, Ashley SW, Whang EE: Treatment outcomes associated with surgery for gallbladder cancer: a 20-year experience. J Gastrointest Surg 8:183–190, 2004
Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ Cancer statistics. CA Cancer J Clin 55:10–30, 2005
Kawamoto T, Shoda J, Irimura T, Miyahara N, Furukawa M, Ueda T, Asano T, Kano M, Koike N, Fukao K, Tanaka N, Todoroki T: Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder. Clin Cancer Res 7:1333–1342, 2001
Kim YW, Huh SH, Park YK, Yoon TY, Lee SM, Hong SH: Expression of the c-erb-B2 and p53 protein in gallbladder carcinomas. Oncol Rep 8:1127–1132, 2001
Kohya N, Miyazaki K, Matsukura S, Yakushiji H, Kitajima Y, Kitahara K, Fukuhara M, Nakabeppu Y, Sekiguchi M: Deficient expression of O(6)-methylguanine-DNA methyltransferase combined with mismatch-repair proteins hMLH1 and hMSH2 is related to poor prognosis in human biliary tract carcinoma. Ann Surg Oncol 9:371–379, 2002
Kwon SY, Chang HJ: Clinicopathological study of unsuspected carcinoma of gallbladder. J Korean Med Science 12:519–522, 1997
Lee HS, Lee HK, Kim HS, Yang HK, Kim WH: Tumour suppressor gene expression correlates with gastric cancer prognosis. J Pathol 200:39–46, 2003
Levy AD, Murakata LA, Rohrmann CA: Gallbladder carcinoma: radiologic-pathologic correlation. Radiographics 21:295–314, 2001
Li X, Hui AM, Shi YZ, Takayama T, Makuuchi M: Reduced p21(WAF1/CIP1) expression is an early event in gallbladder carcinogenesis and is of prognostic significance for patients with carcinomas of the gallbladder. Hum Pathol 32:771–777, 2001
Misra S, Chaturvedi A, Goel MM, Mehrotra R, Sharma ID, Srivastava AN, Misra NC: Overexpression of p53 protein in gallbladder carcinoma in North India. Eur J Surg Oncol 26:164–167, 2000
Nakamura T, Ajiki T, Murao S, Kamigaki T, Maeda S, Ku Y, Kuroda Y: Prognostic significance of S100A4 expression in gallbladder cancer. Int J Oncol 20:937–941, 2002
Oshikiri T, Hida Y, Miyamoto M, Hashida H, Katoh K, Suzuoki M, Nakakubo Y, Hiraoka K, Shinohara T, Itoh T, Kondo S, Katoh H: RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer. Br J Cancer 85:1922–1927, 2001
Rego EM, Wang ZG, Peruzzi D, He LZ, Cordon-Cardo C, Pandolfi PP: Role of promyelocytic leukemia (PML) protein in tumor suppression. J Exp Med 193:521–529, 2001
Rosen DG, Huang X, Deavers MT, Malpica A, Silva EG, Liu J: Validation of tissue microarray technology in ovarian carcinoma. Mod Pathol 17:790–797, 2004
Shi YZ, Hui AM, Li X, Takayama T, Makuuchi M: Overexpression of retinoblastoma protein predicts decreased survival and correlates with loss of p16INK4 protein in gallbladder carcinomas. Clin Cancer Res 6:4096–4100, 2000
Soussi T, Caron de Fromentel C, May P: Structural aspects of the p53 protein in relation to gene evolution. Oncogene 5:945–952, 1990
Takahashi T, Shivapurkar N, Riquelme E, Shigematsu H, Reddy J, Suzuki M, Miyajima K, Zhou X, Bekele BN, Gazdar AF, Wistuba II: Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis. Clin Cancer Res 10:6126–6133, 2004
Torhorst J, Bucher C, Kononen J, Haas P, Zuber M, Köchli OR, Mross F, Dieterich H, Moch H, Mihatsch M, Kallioniemi OP, Sauter G: Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 159:2249–2256, 2001
Varga M, Obrist P, Schneeberger S, Mühlmann G, Felgel-Farnholz C, Fong D, Zitt M, Brunhuber T, Schäfer G, Gastl G, Spizzo G: Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival. Clin Cancer Res 10:3131–3136, 2004
Wistuba II, Sugio K, Hung J, Kishimoto Y, Virmani AK, Roa I, Albores-Saavedra J, Gazdar AF: Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res 55:2511–2515, 1995
Wistuba II, Tang M, Maitra A, Alvarez H, Troncoso P, Pimentel F, Gazdar AF: Genome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma. Cancer Res 61:3795–3800, 2001
Wistuba II, Ashfaq R, Maitra A, Alvarez H, Riquelme E, Gazdar AF: Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma. Am J Pathol 160:2073–2079, 2002
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chang, H.J., Yoo, B.C., Kim, S.W. et al. Significance of PML and p53 protein as molecular prognostic markers of gallbladder carcinomas. Pathol. Oncol. Res. 13, 326–335 (2007). https://doi.org/10.1007/BF02940312
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02940312